One of the most misunderstood parts of testosterone medicine is the relationship between testosterone treatment and fertility. Many men assume that raising testosterone must support fertility. In fact, the opposite can happen when treatment uses exogenous testosterone. That is exactly why fertility goals need to be discussed before treatment begins, not after sperm counts have already fallen.
Why testosterone treatment can reduce sperm production
Sperm production depends on the testis receiving strong signals from LH and FSH. Exogenous testosterone can suppress those signals by telling the brain and pituitary that enough androgen is already present. That lowers intratesticular testosterone and can impair spermatogenesis[1]. Some men recover after stopping TRT, but the timeline is variable and can be stressful for couples trying to conceive.
Why enclomiphene is different
Enclomiphene does not replace testosterone from the outside. It works upstream by increasing LH and FSH, which can stimulate the testis to produce more testosterone internally. For men with secondary or functional hypogonadism, that creates a more fertility-minded treatment logic than standard TRT[2].
Regulatory note: Enclomiphene is not an FDA-approved treatment for male hypogonadism or male infertility in the United States. It should be discussed as a clinician-directed, monitored option with transparent counseling about product source, evidence limits, and alternatives.
When enclomiphene makes more sense
- the patient wants to preserve fertility now or within the next few years
- morning testosterone is repeatedly low and symptoms are compatible with hypogonadism
- LH and FSH are low or inappropriately normal rather than clearly elevated
- the testes appear capable of responding, and the main issue is central or functional suppression
When TRT may still be used
TRT can still be appropriate when fertility is not a goal, when the man has primary hypogonadism, or when the physiology does not support a response to gonadotropin stimulation. It is also the better-studied replacement path for many men with confirmed testosterone deficiency who are not trying to maintain sperm production.
Why fertility workup should not be skipped
If fertility is part of the question, semen analysis belongs in the conversation. A man can have low testosterone and still have adequate semen parameters, or have fertility problems for reasons that extend well beyond testosterone alone. Current fertility guidelines also emphasize that endocrine testing, history, physical exam, and semen analysis all matter in the infertile couple[3][4].
Important limits to the evidence
The best enclomiphene data are encouraging, but the studies are not large enough to promise the same outcome for every patient. Preserved sperm counts in a trial do not equal assured pregnancy[2][5], and men with azoospermia, severe oligospermia, prior anabolic steroid exposure, pituitary disease, or primary testicular failure often need a more specialized reproductive workup.
What this means clinically
If a man with low testosterone says, “I want to feel better and I may want children,” that is exactly the situation where a generic low-T treatment plan can go wrong. The question is no longer just whether testosterone is low. It is whether the treatment plan respects the reproductive goal.
Conclusion
Enclomiphene tends to make more sense than TRT when a man has low testosterone symptoms, a secondary or functional hormone pattern, and an active interest in preserving fertility. TRT still has an important place, but not as the default option for every reproductive-age man with low testosterone.
References
- [1] Naelitz BD et al. Testosterone replacement therapy and spermatogenesis in reproductive age men. Nat Rev Urol. 2025. PMID 40346275.
- [2] Kim ED et al. Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone. BJU Int. 2016. PMID 26496621.
- [3] Schlegel PN et al. Diagnosis and treatment of infertility in men: AUA/ASRM guideline part I. Fertil Steril. 2021. PMID 33309062.
- [4] Brannigan RE et al. Updates to Male Infertility: AUA/ASRM Guideline (2024). J Urol. 2024. PMID 39145501.
- [5] Thomas J et al. Efficacy of Clomiphene Citrate Versus Enclomiphene Citrate for Male Infertility Treatment: A Retrospective Study. Cureus. 2023. PMID 37546076.
